港股異動 | 利好疊加 香港航天科技(1725.HK)3日累計飆漲近60%
格隆匯4月7日丨香港航天科技(1725.HK)再度拉昇漲超13%,3日累計漲幅近60%,現報20.6港元,總市值63.6億港元。公司日前公吿2021年收入升18.7%至6.5億元。公司金紫荊-齊魯衞星星座第一期將由9顆衞星組成,其建造和發射將於今年完成。其中,首發試驗星金紫荊衞星六號,預計今年7月發射。此前公司擬與香港城市大學工學院合作研發先進衞星科技及相關應用。2023年集團將繼續投產批量多顆遙感衞星。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.